xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
基本信息
- 批准号:8559980
- 负责人:
- 金额:$ 157.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAfricanAfrican AmericanAlabamaAmericanAreaBiometryBlindnessCaliforniaCaucasiansCaucasoid RaceClinicalCollaborationsCorneaCustomDNADataData AnalysesData Coordinating CenterData SetDatabase Management SystemsDatabasesDetectionDevelopmentDiagnosisDiagnosticDiseaseDrug TargetingEarEarly InterventionEnrollmentEthnic groupEtiologyEuropeanEvaluation StudiesEyeFamilyFunctional disorderFutureGenesGeneticGenomeGenotypeGlaucomaGoalsInstitutesLarge-Scale SequencingLeadLinkage DisequilibriumLocationMapsMedical GeneticsMedical centerMedicineMeta-AnalysisMethodsMinorityNew YorkOptic NervePathogenesisPathway interactionsPatientsPatternPennsylvaniaPersonsPhenotypePhysiologic Intraocular PressurePopulationPrimary Open Angle GlaucomaPrincipal InvestigatorPrivate PracticeProxyQuality ControlRaceRisk FactorsRunningSamplingSeveritiesSingle Nucleotide PolymorphismStagingStudy SubjectTechnologyTestingThickTimeUniversitiesVariantVisualVisual FieldsVisual impairmentbasecaucasian Americanclinical research sitecohortdesigneffective therapyexomegenetic variantgenome wide association studyhigh riskimprovedinnovationpredictive modelingpublic health relevancerepositorytrait
项目摘要
PROJECT SUMMARY
Glaucoma results in vision loss due to damage of the optic nerve that is irreversible if undetected or
untreated. The most common form of glaucoma is primary open angle glaucoma (POAG). While glaucoma
affects all races, persons of African descent are disproportionately affected; studies show African Americans
(AAs) are about four to five times more likely than Caucasian Americans to develop the disease. Glaucoma is
the leading cause of irreversible blindness in Americans of African descent, and the second leading cause in
all Americans.
The lack of understanding about the etiology of POAG impedes our ability to identify and treat it early in
its development. Evidence of genetic contribution in the pathogenesis of POAG is well established. Since
POAG tends to run in families, it is critical to identify the genetic basis of the disease in order to develop
effective therapies for early intervention.
While genome wide association studies (GWAS) for glaucoma have been completed for Caucasian
populations, evidence from other studies suggests that a GWAS of glaucoma specific genes to the African-
American population will yield unique and important findings for both this population and for glaucoma in
general. A better understanding of the relationship among the stage of disease, the rate of change, ancestry,
and other important risk factors being tracked in the ongoing African Descent and Glaucoma Study (ADAGES)
will allow us to evaluate the relationship between genetics, visual loss and structural damage in this high-risk
cohort.
The scientific plan for this new study focuses on glaucoma in ~2000 African-Americans by detailed
phenotyping of new subjects, acquisition of samples from both new and established previously phenotyped
study subjects for a repository, establishment of a data coordinating center, and genome wide association
studies. The recruitment, enrollment, and phenotyping of both established and new subjects occurs at four
clinical centers, University of California (UCSD), New York Eye and Ear Infirmary New York University of
Medicine, a private practice in the Atlanta area, and the University of Alabama at Birmingham. UCSD is also
the location for the Data Coordinating Center and the Repository with Robert N. Weinreb as Principal
Investigator. CSMC will do the genotyping with a GWAS panel of ~2.5 million single nucleotide polymorphisms
(SNPs) plus an exome set of ~300,000 SNPs using the Illumina Omni2.5 plus exome platform under the
direction of Jerome Rotter and Kent Taylor. CSMC will also provide GWAS and exome data for 3435 controls.
Comparison and confirmation of the GWAS and exome SNPs and data associated with glaucoma will be
compared and confirmed with the University of Pennsylvania's similar glaucoma study.
项目总结
青光眼由于视神经损伤而导致视力丧失,如果未被发现或
未经治疗。最常见的青光眼形式是原发性开角型青光眼(POAG)。而青光眼
影响到所有种族,非洲裔人受到的影响不成比例;研究表明,非洲裔美国人
(AA)患这种疾病的可能性大约是高加索美国人的四到五倍。青光眼是
非洲裔美国人不可逆转失明的首要原因,以及
都是美国人。
对POAG的病因缺乏了解阻碍了我们早期识别和治疗它的能力
它的发展。基因在POAG发病机制中的作用的证据是确凿的。自.以来
POAG倾向于家族遗传,确定疾病的遗传基础对于疾病的发展至关重要
早期干预的有效疗法。
而针对高加索人的青光眼全基因组关联研究(GWAS)已经完成
在人群中,来自其他研究的证据表明,非洲人青光眼特异基因的GWAs-
美国人群将为这一人群和青光眼患者带来独特而重要的发现
将军。更好地理解疾病阶段、变化率、血统、
以及正在进行的非洲人下降和青光眼研究中追踪的其他重要风险因素(ADAGES)
将使我们能够评估遗传学、视力丧失和结构损伤之间的关系
一群人。
这项新研究的科学计划详细介绍了约2000名非裔美国人中的青光眼
新受试者的表型鉴定,从新的和已建立的表型鉴定中获取样本
研究对象为存储库,建立数据协调中心,并建立全基因组关联
学习。现有学科和新学科的招募、注册和表型鉴定都在四点进行。
临床中心,加州大学(UCSD),纽约大学眼耳医院
亚特兰大地区的一家私人诊所,以及阿拉巴马大学伯明翰分校。加州大学洛杉矶分校也是
以Robert N.Weinreb为负责人的数据协调中心和存储库的位置
调查员。CSMC将利用一个由大约250万个单核苷酸多态组成的GWAS小组进行基因分型
(SNPs)加上一组约300,000个SNPs,使用Illumina Omni2.5 Plus外显子组平台
导演杰罗姆·罗特和肯特·泰勒。CSMC还将提供3435个对照的GwA和EXOME数据。
与青光眼相关的GWASNPs和外显子SNPs和数据的比较和确认将是
与宾夕法尼亚大学的类似青光眼研究进行了比较和证实。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerome I Rotter其他文献
URIDINE MONOPHOSPHATE KINASE: A NEW GENETIC MARKER OF SUSCEPTIBILITY TO HAEMOPHILUS INFLUENZAE TYPE B DISEASE: 158
尿苷单磷酸激酶:B 型流感嗜血杆菌疾病易感性的新遗传标记:158
- DOI:
10.1203/00006450-198507000-00178 - 发表时间:
1985-07-01 - 期刊:
- 影响因子:3.100
- 作者:
Gloria M Petersen;Diana R Silimperi;Edward M Scott;David R Hall;Jerome I Rotter;Joel I Ward - 通讯作者:
Joel I Ward
701 CHROMOSOMAL VARIANTS IN HABITUAL ABORTION
习惯性流产中的 701 种染色体变异
- DOI:
10.1203/00006450-198104001-00724 - 发表时间:
1981-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Bruce D Blumberg;Jeffery D Shulkin;Jerome I Rotter;T K Mohandas;Michael M Kaback - 通讯作者:
Michael M Kaback
Jerome I Rotter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerome I Rotter', 18)}}的其他基金
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
- 批准号:
9127971 - 财政年份:2013
- 资助金额:
$ 157.78万 - 项目类别:
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
- 批准号:
8915183 - 财政年份:2013
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7848277 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7434575 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7249179 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
GENE APPROACH TO IMMUNOPHENOTYPIC SUBGROUPS OF CROHN'S DISEASE
克罗恩病免疫表型亚群的基因方法
- 批准号:
7487325 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7624596 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
GENES AS IMMUNOPHENOTYPIC SUBGROUPS OF CROHN'S DISEASE
基因作为克罗恩病的免疫表型亚群
- 批准号:
7024923 - 财政年份:2005
- 资助金额:
$ 157.78万 - 项目类别:
Genetics of Diabetic Retinopathy in Hispanics
西班牙裔糖尿病视网膜病变的遗传学
- 批准号:
7995175 - 财政年份:2004
- 资助金额:
$ 157.78万 - 项目类别:
Genetics of Diabetic Retinopathy in Hispanics
西班牙裔糖尿病视网膜病变的遗传学
- 批准号:
7909498 - 财政年份:2004
- 资助金额:
$ 157.78万 - 项目类别:
相似海外基金
Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
- 批准号:
2306671 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
- 批准号:
10714464 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
- 批准号:
10593806 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
- 批准号:
2327055 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
- 批准号:
10782674 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
- 批准号:
10738855 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
- 批准号:
23K00376 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
- 批准号:
10633624 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别: